Logo Image
News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Career Center|
Radiation Oncology|
Surgery
Advertisement

Giorgio Gandaglia, MD

Advertisement

Articles by Giorgio Gandaglia, MD

Node-Positive Prostate Cancer: A Call for Level 1 Evidence

ByGiorgio Gandaglia, MD,R. Jeffrey Karnes, MD,Cesare Cozzarini, MD,Francesco Montorsi, MD,Alberto Briganti, MD
February 15th 2015

Despite the lack of level 1 evidence, retrospective studies support the need for appropriate local treatment, even in the context of node-positive disease.

Extended Lymph Node Dissection in Prostate Cancer: A Procedure With Therapeutic Utility

ByGiorgio Gandaglia, MD,Ettore Di Trapani, MD,Alberto Briganti, MD
July 16th 2014

Extended pelvic lymph node dissection represents the most accurate procedure for the detection of lymph node metastases in prostate cancer.

Advertisement

Latest Updated Articles

  • Extended Lymph Node Dissection in Prostate Cancer: A Procedure With Therapeutic Utility
    Extended Lymph Node Dissection in Prostate Cancer: A Procedure With Therapeutic Utility

    July 16th 2014

  • Node-Positive Prostate Cancer: A Call for Level 1 Evidence
    Node-Positive Prostate Cancer: A Call for Level 1 Evidence

    February 15th 2015



Advertisement
Advertisement

Trending on CancerNetwork

1

FDA Approves SC Amivantamab for Recurrent/Metastatic HNSCC

2

Setting Up an HDR Brachytherapy Program Amid a National Decline

3

Zamto-Cel Improves EFS vs R-GemOx in Transplant-Ineligible R/R LBCL

4

16-Fraction PMRT With IMN Irradiation Noninferior in High-Risk Breast Cancer

5

CD38-Targeted Immuno-PET Helps Detect Active Multiple Myeloma

  • About
  • Advertise
  • CureToday.com
  • OncLive.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Editorial
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us